Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

4

Revenue 2017

Herceptin

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Herceptin was produced by Roche.

Reactivating drug research programmes

Reactivating drug research programmes However, as drugs like Herceptin have shown, as long as there is a high degree of efficacy in a small group of patients, such treatments can still be commercially viable.

Roche trumpets APHINITY data, but did it hit the mark?

Roche trumpets APHINITY data, but did it hit the mark? One year of adjuvant therapy with Perjeta plus Herceptin and chemotherapy can cost upwards of $150, 000, roughly twice the cost of Herceptin alone. ... A large chunk of Perjeta's $5bn sales forecast has been attributed to adjuvant use alongside Herceptin

FDA panel backs Puma's breast cancer drug, with reservations

FDA panel backs Puma's breast cancer drug, with reservations That led to calls at the meeting to limit the use of the drug to women who have taken Herceptin in the past two years, although shares in the company surged ... trial of Herceptin plus Perjeta (pertuzumab), which if positive could end up replacing

WHO pilots scheme to make biosimilars available to poorer countries

WHO pilots scheme to make biosimilars available to poorer countries Plans to expand prequalification scheme to medicines such as Roche’s Rituxan and Herceptin. ... The move comes as biosimilars of Rituxan and Herceptin are starting to find their way onto the market.

A new decade of disruption: meeting the biosimilar challgenge

A new decade of disruption: meeting the biosimilar challgenge An example can be seen in Roche’s introduction of an injectable alternative to its intravenous formulation of Herceptin (trastuzumab) in 2013 before the drug lost exclusivity in Europe.

[ Previous 5 results ] 10 11 12 13 14 15 16 17 18 19 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Delivering true value: what does it mean for KAM in cancer care?
Lisa Alderson, Business Development Director at Wilmington Healthcare, explores the challenges that pharma’s KAM teams face in engaging with the NHS and how they must evolve...
Pharma M&A
Pharma funding and M&A in 2020
Why pharma M&A has continually bucked the trend...
Behaviour change through medical education: How can we turn aspiration into reality?
Practical, evidence-based insights into a CME process that aims to effect measurable behaviour change...

Infographics